No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
DOCS240816C32500
- 0.65
- +0.09+16.07%
15min DelayClose Jul 19 15:59 ET
0.65High0.65Low
0.65Open0.56Pre Close119 Volume653 Open Interest32.50Strike Price7.74KTurnover68.84%IV17.47%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.65Extrinsic Value100Contract SizeAmericanOptions Type0.2551Delta0.0621Gamma38.92Leverage Ratio-0.0331Theta0.0046Rho9.93Eff Leverage0.0241Vega
Intraday
- 5D
- Daily
News
Street Calls of the Week: Upgrades for Apple and Shopify; Downgrade for Doximity
Notable Analyst Calls This Week: Shopify, CrowdStrike and Chegg Among Top Picks
Evercore ISI Reaffirms Their Hold Rating on Doximity (DOCS)
Top Gap Ups and Downs on Thursday: NVS, PGR, INFY and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Press Release: Doximity to Release Fiscal 2025 First Quarter Results on August 8, 2024
Doximity to Release Fiscal 2025 First Quarter Results on August 8, 2024 SAN FRANCISCO--(BUSINESS WIRE)--July 18, 2024-- Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical
Express News | Doximity Shares Are Trading Lower After Wells Fargo Downgraded the Stock From Equal-Weight to Underweight and Lowered Its Price Target From $27 to $19
Comments
$Doximity(DOCS.US$
from the list. so far its hold that daily support 27.61/27.93 we could see a retest of that montly 28.82/29.26 and maybe 30.40/30.74. if DOCS breaks below, it could test 26.97 or lower 25.98/26.69.
from the list. so far its hold that daily support 27.61/27.93 we could see a retest of that montly 28.82/29.26 and maybe 30.40/30.74. if DOCS breaks below, it could test 26.97 or lower 25.98/26.69.
2
Doximity's high P/E ratio is backed by its promising earnings outlook. Shareholders, confident in future earnings, are holding onto their shares. The company's robust earnings growth and positive future outlook bolster its share price.
2
The telehealth market shone brightly, valued at $128.12 billion. The market is poised for a stellar ascent, forecasted to skyrocket from $142.96 billion in 2023 to a staggering $504.24 billion by 2030. This growth, marked by a robust 19.7% CAGR, highlights the sector’s burgeoning potential, as noted by Fortune Business Insights. The growth of telehealth is significant. It underscores its transformative impact on the future landscape of healthcare.
![]()
$Teladoc Health(TDOC.US$
A...
A...
+2
7
Analysts from William Blair and Raymond James rate DOCS shares as 'Outperform', remaining optimistic about the company's future. They find the solid results and improved guidance range to be a positive step.
Doximity's underpriced shares and forecasted profitability increase its appeal among big growth investors. Its bright future prospects are not entirely factored into its current share price. However, it's recommended to examine the company's finance before investment.
Read more